Non-[18F]FDG PET in clinical oncology

被引：92

作者：

Groves, Ashley M. ^{[1
]}

Win, Thida

Ben Haim, Simona

Ell, Peter J.

机构：

[1] UCL, Inst Nucl Med, London NW1 2BU, England

[2] Lister Hosp, Stevenage, Herts, England

来源：

LANCET ONCOLOGY | 2007年 / 8卷 / 09期

关键词：

D O I：

10.1016/S1470-2045(07)70274-7

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

PET is an exquisitely sensitive molecular imaging technique using positron-emitting radioisotopes coupled to specific ligands. Many biological targets of great interest can be imaged with these radiolabelled ligands. This review describes the current status of non-18-fluorodeoxyglucose PET tracers that have a potential clinical effect in oncology. With the help of these tracers, knowledge is being acquired on the molecular characterisation of specific tumours, their biological signature, and postinterventional response. The potential role of these imaging probes for tumour detection and monitoring is progressively being recognised by clinical oncologists, biologists, and pharmacologists.

引用

页码：822 / 830

页数：9

共 50 条

[41] Whole-Body [18F]-FDG-PET/MRI for Oncology: A Consensus Recommendation
Umutlu, Lale
Beyer, Thomas
Grueneisen, Johannes Stefan
Rischpler, Christoph
Quick, Harald H.
Veit-Haibach, Patrick
Eiber, Matthias
Purz, Sandra
Antoch, Gerald
Gatidis, Sergios
Nikolaou, Konstantin
Schaefer, Juergen F.
Rausch, Ivo
Herrmann, Ken
Herrmann, K.
Krause, B. J.
Schoenberg, S. O.
Umutlu, L.
Anton, F.
Antoch, G.
Hacker, M.
Krause, B. J.
Luster, M.
Neumann, S.
Schoenberg, S. O.
Vorwerk, D.
Schoenberg, Stefan
Vorwerk, Dierk
Antoch, Gerald
Anton, Frank
Neumann, Stefan
ROFO-FORTSCHRITTE AUF DEM GEBIET DER RONTGENSTRAHLEN UND DER BILDGEBENDEN VERFAHREN, 2019, 191 (04): : 289 - 297
[42] Whole-Body [18F]-FDG-PET/MRI for Oncology: A Consensus Recommendation
Umutlu, Lale
Beyer, Thomas
Grueneisen, Johannes Stefan
Rischpler, Christoph
Quick, Harald H.
Veit-Halbach, Patrick
Eiber, Matthias
Purz, Sandra
Antoch, Gerald
Gatidis, Sergios
Nikolaou, Konstantin
Schaefer, Jurgen F.
Rausch, Ivo
Herrmann, Ken
Herrmann, K.
Krause, B. J.
Schoenberg, S. O.
Umutlu, L.
Anton, F.
Antoch, G.
Hacker, M.
Krause, B. J.
Luster, M.
Neumann, S.
Schoenberg, S. O.
Vorwerk, D.
NUKLEARMEDIZIN-NUCLEAR MEDICINE, 2019, 58 (02): : 68 - 76
[43] Multicentre assessment and monitored use of [18F]FDG-PET in oncology: the Spanish experience
Manuel Rodríguez-Garrido
Cristina Asensio-del-Barrio
European Journal of Nuclear Medicine and Molecular Imaging, 2008, 35 : 296 - 304
[44] [18f]FDG PET in diagnostics and treatment vasculitis
Manukova, V.
Manukova, V
Lyuosev, A.
Panchkovskaya, E.
Roudas, M.
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2012, 39 : S402 - S402
[45] Neurolymphomatosis diagnosed on [18F]FDG PET/CT
Benameur, Yassir
Sahel, Omar Ait
Oueriagli, Salah Nabih
Doudouh, Abderrahim
NUCLEAR MEDICINE REVIEW, 2023, 26 : 96 - 97
[46] Tumor Metabolic Phenotypes on 18F FDG PET
Wong, Ching-yee Oliver
Khong, Pek-lan
JOURNAL OF NUCLEAR MEDICINE, 2009, 50 (06) : 1010 - 1011
[47] [18F]FDG PET/MRI in rectal cancer
Crimi, Filippo
Valeggia, Silvia
Baffoni, Luca
Stramare, Roberto
Lacognata, Carmelo
Spolverato, Gaya
Albertoni, Laura
Spimpolo, Alessandro
Evangelista, Laura
Zucchetta, Pietro
Cecchin, Diego
Pucciarelli, Salvatore
ANNALS OF NUCLEAR MEDICINE, 2021, 35 (03) : 281 - 290
[48] Multicentre assessment and monitored use of [18F]FDG-PET in oncology:: the Spanish experience
Rodriguez-Garrido, Manuel
Asensio-del-Barrio, Cristina
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2008, 35 (02) : 296 - 304
[49] PET beyond 18F-FDG: second generation PET tracers in clinical oncology
Brouwers, A. H.
Glaudemans, A. W. J. M.
De Vries, E. F. J.
QUARTERLY JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2015, 59 (01): : 1 - 3
[50] Applications of (18)(F) FDG PET/CT in Oncology
Fikri, A. S. Fathinul
Nordin, A. J.
Cheah, Y. K.
Saad, F. N. Ahmad
PERTANIKA JOURNAL OF SCIENCE AND TECHNOLOGY, 2015, 23 (01): : 1 - 12

← 1 2 3 4 5 →